Global Acute Kidney Injury Market Trends and Growth Analysis 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Acute Kidney Injury Market Over The Five-Year Period 2025–2029?

The acute kidney injury market size has experienced strong growth in recent years. Projections indicate it will expand from $5.37 billion in 2024 to $5.72 billion in 2025, at a compound annual growth rate (CAGR) of 6.6%. The expansion observed historically is attributable to the increasing prevalence of chronic diseases, rising geriatric population, growing incidence of hospital-acquired infections, increasing awareness about kidney health, and advancements in critical care medicine.

The acute kidney injury market is projected to experience substantial expansion over the coming years, set to reach $7.33 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.4%. The anticipated growth during this period is driven by factors such as the increasing incidence of sepsis, the expanding need for personalized treatment, more government healthcare initiatives, escalating healthcare spending in developing economies, and a significant emphasis on personalized medicine and regenerative therapies. Key trends anticipated for the forecast timeframe encompass wearable dialysis devices, the application of artificial intelligence for treatment optimization, portable renal replacement therapy systems, advancements in continuous renal replacement therapy (CRRT), remote monitoring solutions, and the integration of telemedicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21079&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Acute Kidney Injury Industry?

The rising occurrence of diabetes is projected to fuel the expansion of the acute kidney injury market moving forward. Diabetes encompasses a group of metabolic illnesses identified by elevated blood glucose levels, either resulting from the body’s inability to produce adequate insulin or cells failing to react appropriately to insulin. The escalating incidence of diabetes is driven by elements such as increasing obesity rates, poor dietary choices, sedentary routines, an aging demographic, and improved awareness and diagnostic capabilities. Acute kidney injury initiates metabolic and inflammatory alterations that can impact insulin resistance and glucose regulation, signifying a complex interaction that may influence the advancement and management of diabetes. For instance, in March 2024, data from the Office for Health Improvement & Disparities, a UK government department, indicated that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes saw an increase of 22%, and for type 2 diabetes, it grew by 21%, concurrently, the percentage achieving target HbA1c levels ascended to 37.9%, representing the highest value ever reported by the National Diabetes Audit (NDA). Therefore, the heightened prevalence of diabetes is propelling the growth of the acute kidney injury market.

Which Key Segments Fueling The Acute Kidney Injury Market?

The acute kidney injurymarket covered in this report is segmented –

1) By Injury: Pre-Renal Kidney Injury; Post-Renal Kidney Injury; Intrinsic Kidney Injury

2) By Treatment Type: Dialysis; Drug Therapy; Urinary Implants

3) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users

Subsegments:

1) By Pre-Renal Kidney Injury: Hypovolemia; Heart Failure-Related Injury; Sepsis-Induced Injury; Renal Artery Stenosis; Hepatorenal Syndrome

2) By Post-Renal Kidney Injury: Ureteral Obstruction; Bladder Outlet Obstruction; Prostate Enlargement (Benign Prostatic Hyperplasia); Kidney Stones; Tumors Affecting Urinary Tract

3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN); Acute Interstitial Nephritis (AIN); Glomerulonephritis; Vasculitis; Rhabdomyolysis-Induced Injury

Which Key Trends Are Expected To Influence The Acute Kidney Injury Market In The Coming Years?

Companies prominently involved in the acute kidney injury (AKI) market are concentrating on securing regulatory authorizations to expand their product portfolios and introduce new treatment modalities. Regulatory approvals signify the official permission granted by governing bodies, such as the FDA or EMA, enabling a product’s commercialization and sale after it meets established safety, efficacy, and quality criteria. As an illustration, in December 2023, Mission Therapeutics Ltd., a UK-based biotechnology firm, received FDA clearance to commence a Phase II clinical trial for its flagship compound, MTX652, which targets acute kidney injury (AKI) in patients at elevated risk following cardiac surgery. This compound is engineered to address key pathways implicated in kidney injury and repair, with the goals of reducing inflammation, preventing further kidney damage, and promoting recovery. A notable aspect of this trial is its focus on utilizing innovative therapeutic mechanisms to tackle the underlying molecular causes of AKI, potentially offering more potent treatment options compared to existing interventions. The Phase II trial will evaluate MTX652’s safety, effectiveness, and pharmacokinetics, generating essential data that could support broader clinical acceptance and potential approval.

Who Are The Key Multinational Companies Dominating The Acute Kidney Injury Market?

Major companies operating in the acute kidney injury market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co. Ltd., Teva Pharmaceutical Industries Ltd., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co. Ltd., Quark Pharmaceuticals Inc., Kringle Pharma Inc., Aptabio Therapeutics Inc., Alexion Pharmaceuticals Inc., Alloksys Life Sciences B.V., AM-Pharma B.V., Arch Biopartners Inc., Guard Therapeutics International AB

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/acute-kidney-injury-global-market-report

How Does The Acute Kidney Injury Market Perform Across Key Geographic Regions?

North America was the largest region in the acute kidney injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute kidney injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Acute Kidney Injury Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21079&type=smp

Browse Through More Reports Similar to the Global Acute Kidney Injury Market 2025, By The Business Research Company

Diabetic Kidney Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Kidney Transplant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Artificial Kidney Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-kidney-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795